Monitoring of Biopsy-Proven Interstitial Polyomavirus Nephritis in Kidney and Kidney Pancreas Transplant Recipients

Completed

• Conditions: Polyomavirus

• Registration Number: NCT00374283
• Lead Sponsor: University of Cincinnati

Brief Summary

Evaluate techniques for monitoring the course of interstitial therapy for polyomavirus nephritis in kidney and kidney pancreas transplant recipients by monitoring blood, urine, and renal transplant biopsies of patients affected by polyomavirus.

Detailed Description

Evaluate techniques for monitoring the course of interstitial therapy for polyomavirus nephritis in kidney and kidney pancreas transplant recipients by monitoring blood, urine, and renal transplant biopsies of patients affected by polyomavirus.

Study Timeline

• Study Start: 2001-06
• Study First Submitted: 2006-09-08
• Study First Submitted QC: 2006-09-08
• Study First Posted: 2006-09-11
• Study Completion: 2007-10
• Status Verified: 2007-12
• Last Update Submitted: 2007-12-20
• Last Update Posted: 2008-01-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Recipients of a kidney or kidney pancreas transplant diagnosed with biopsy proven interstitial nephritis due to polyomavirus.
• Age 18 to 70 years.
• Capable of providing written informed consent.

Exclusion Criteria

• Age less than 18 years or greater than 70 years.
• Patient is on chronic warfarin or heparin therapy or has a disease that puts them at risk of bleeding.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (2)

University of Cincinnati; 🇺🇸 Cincinnati, Ohio, United States

The Christ Hospital; 🇺🇸 Cincinnati, Ohio, United States